No CLE

Third-party releases in view of Behrmann v. National Heritage Foundation. Indubitable equivalent in the context of an operating company. In re River Road: what is the future of credit-bidding and indubitable equivalent plans? One impaired class: by plan or by debtor? New issues in pre-packaged plans.

Corporate Restructurings in Mexico under the Ley de Concurso Mercantil The panel will focus on some of the significant corporate restructurings and leading bankruptcy decisions in Mexico rendered under the Ley de Concurso Mercantil. Holdings and implications from decisions such as Durango, CCM and Vitro will be discussed.

The panel will focus on some of the significant corporate restructurings and leading bankruptcy decisions in Mexico rendered under the Ley de Concurso Mercantil. Holdings and implications from decisions such as Durango, CCM and Vitro will be discussed.

Cross-Border Recognition Issues between U.S. and Mexico The panel will discuss attempts to apply creditor protections and applying the concept manifestly against public policy.

The panel will discuss attempts to apply creditor protections and applying the concept manifestly against public policy.

Do “Out-of-the-Money” Creditors Have Standing? There are many chapter 11’s filed primarily to sell the collateral for undersecured creditors—meaning that there isn’t any value generated for unsecured creditors or equity. This panel will explore the various issues that result such as basic standing and the appropriateness of forming and maintaining a creditors committee and an equity committee. The panel will also discuss the various arguments put forth to justify a carveout or “gift” for unsecured creditors and the often used “pay-to-play” rule occasionally asserted by out-of-the-money creditor groups. It will also examine ways to identify unencumbered assets early in the case and the possible benefits of keeping them free from post-petition liens granted to DIP Lenders. Lastly, the panel will discuss ways to maximize the Chapter 5 claims and the use of liquidating assets.

What do the new fee guidelines from the U.S. Trustee mean for your practice? How is new Rule 2019 affecting practice and disclosure?